NASDAQ:INGNInogen Stock Price, Forecast & News

Inogen's stock was trading at $40.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INGN stock has decreased by 9.5% and is now trading at $36.77. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Inogen.

Inogen is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Inogen.

Inogen Inc (NASDAQ:INGN) posted its quarterly earnings data on Tuesday, May, 5th. The medical technology company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.04. The medical technology company had revenue of $88.49 million for the quarter, compared to analysts' expectations of $82.33 million. Inogen had a net margin of 3.90% and a return on equity of 4.93%. Inogen's quarterly revenue was down 1.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.24 earnings per share. View Inogen's earnings history.

7 analysts have issued 1 year price targets for Inogen's stock. Their forecasts range from $45.00 to $80.00. On average, they expect Inogen's stock price to reach $60.80 in the next year. This suggests a possible upside of 65.4% from the stock's current price. View analysts' price targets for Inogen.

News headlines about INGN stock have been trending very negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inogen earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Inogen.

Inogen saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 2,830,000 shares, a drop of 6.0% from the May 31st total of 3,010,000 shares. Based on an average daily volume of 427,500 shares, the days-to-cover ratio is currently 6.6 days. Currently, 15.5% of the shares of the company are short sold. View Inogen's Current Options Chain.

Some companies that are related to Inogen include Wound Management Technologies (WNDM), Avanos Medical (AVNS), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Allied Healthcare Products (AHPI), Rewalk Robotics (RWLK), Histogenics (HSGX), Precision Therapeutics (POAI), Ocugen (OCGN) and Bionik Laboratories (BNKL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), Medivation (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), First Solar (FSLR), Netflix (NFLX), Intel (INTC) and Advanced Micro Devices (AMD).

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of INGN stock can currently be purchased for approximately $36.77.

Inogen has a market capitalization of $810.78 million and generates $361.94 million in revenue each year. The medical technology company earns $20.95 million in net income (profit) each year or $1.07 on an earnings per share basis. Inogen employs 1,020 workers across the globe.

The official website for Inogen is www.inogen.com.

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]